USC/Norris Cancer Hospital
Welcome,         Profile    Billing    Logout  
 3 Trials 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mohrbacher, Ann
ST-001-010, NCT04234048: Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Recruiting
1
46
US
Fenretinide, nanoFenretinide, ST-001, 4-HPR, N-(4-hydroxyphenyl)retinamide, N-(4-hydroxyphenyl)-all-trans-retinamide
SciTech Development, LLC, Rush University Medical Center
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma, Peripheral T-Cell Lymphoma, Not Classified, Primary Cutaneous T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, Cutaneous T-cell Lymphoma, Follicular T-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Sézary's Disease, Mycosis Fungoides
05/25
11/25

Download Options